A dose-outcome analysis of risperidone

Journal of Clinical Psychiatry

Volumn 60, Issue 11, 1999, Pages 771-775

  Love, Raymond C ^b   Conley, Robert R ^a   Kelly, Deanna L ^b   Bartko, John J ^b  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG EFFICACY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; TITRIMETRY; TREATMENT OUTCOME;

EID: 0032707588     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v60n1110     Document Type: Article

References (12)

1. Peralta V, Cuesta MJ, Caro F, et al. Neuroleptic dose and schizophrenic symptoms: a survey of prescribing practices. Acta Psychiatr Scand 1994; 90:354-357
2. Bollini P, Pampallona S, Orza MJ, et al. Antipsychotic drugs: is more worse? a meta-analysis of the published randomized controlled trials. Psychol Med 1994;24:307-316
3. Love RC. Novel versus conventional antipsychotic drugs. Pharmacotherapy 1996;16:6-10
4. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835
5. Chouinard G, Jones B, Remington G, et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993;13:25-40
6. Muller-Spahn F. Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol [abstract]. Clin Neuropharmacol 1992;12:90
7. Kleiser E, Lehmann E, Kinzler E, et al. Randomized, double-blind controlled trial of risperidone versus clozapine in patients with chronic schizophrenia. J Clin Psychopharmacol 1995;15:45-51
8. Moller HJ, Bauml J, Ferrero F, et al. Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria and Switzerland. Eur Arch Psychiatry Clin Neurosci 1997;246:291-296
9. Bouchard RH, Demers MF, Merette C, et al. Classical neuroleptics vs risperidone interim 12 months efficacy analysis of a long-term, naturalistic study in schizophrenics. In: Abstracts of the 21st Collegium Internationale Neuro-Psychopharmacologicum Congress; July 12-16, 1998; Glasgow, Scotland. Abstract PT10024
10. Philipo M. Neuroleptic treatment long term: results with risperidone. In: Abstracts of the 21st Collegium Internationale Neuro-Psychopharmacologicum Congress; July 12-16, 1998; Glasgow, Scotland. Abstract PT07034
11. Sajatovic M, Ramirez LF, Belton J, et al. Health resource utilization and risperidone therapy in patients with serious mental illness. In: Abstracts of the 21st Collegium Internationale Neuro-Psychopharmacologicum Congress; July 12-16, 1998; Glasgow, Scotland. Abstract PM04014
12. Procyshyn RM, Zerjav S. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine. Clin Ther 1998;20:1203-1217